Ciclosporin + azathioprine vs tacrolimus + mycophenolic acid for the prevention of rejection in lung transplant recipients

Trial Profile

Ciclosporin + azathioprine vs tacrolimus + mycophenolic acid for the prevention of rejection in lung transplant recipients

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Apr 2014

At a glance

  • Drugs Mycophenolic acid (Primary) ; Tacrolimus (Primary) ; Azathioprine; Ciclosporin
  • Indications Lung transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top